Clinical trials
Transplantation clinical trials
Below are recruiting transplantation clinical trials, each written for real people, not researchers. We’re tracking 1,497 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07209501Enrolling by invitation
Aromatherapy for stem cell transplant patients
This trial tests if inhaling essential oils can help patients who are having a stem cell transplant after high-dose chemotherapy. It aims to see if this is a feasible and acceptable way to feel better during treatment.
SingaporeAges 21–99 - NCT04829136Recruiting
Oral fiber supplement during donor stem cell transplant
This trial tests whether taking a fiber supplement by mouth during a donor stem cell transplant helps patients tolerate treatment and potentially recover better. It’s specifically for adults who are planning a donor (allogeneic) transplant for blood cancers.
Seattle, WashingtonAges 18 years+ - NCT06513091Recruiting
National lung transplant recipient registry study
This study collects information from all lung transplant recipients in the United States to track their health and outcomes over time. It helps doctors learn how to improve care for people who have had a lung transplant.
Phoenix, ArizonaAges Any age - NCT06797258Recruiting
FlexHD for Breast Reconstruction After Mastectomy
This study tests a special type of tissue support (FlexHD Pliable) used during breast reconstruction right after a mastectomy. It may help women who want implants placed above the chest muscle.
Fort Worth, TexasAges 22 years+ - NCT06548958Recruiting
TBI and chemotherapy before a second stem cell transplant
This trial tests a combination of total body irradiation and two chemotherapy drugs as preparation for a second stem cell transplant in people with blood cancers that relapsed or didn't respond to the first transplant.
Suzhou, JiangsuAges 14–70 - NCT07145515Recruiting
Heart preservation device trial for transplant patients
This trial tests a portable device that keeps donor hearts healthy outside the body before transplant. It may help more donor hearts be used, including those from donors after circulatory death and hearts previously considered less suitable.
San Francisco, CaliforniaAges 18 years+ - NCT06555432Recruiting
Study of maribavir for CMV infection after transplant
This study tests a medication called LIVTENCITY (maribavir) for adults in South Korea who have a CMV infection after a transplant. It is for people whose infection has not improved or has become resistant to other antiviral medicines.
SeoulAges 19 years+ - NCT07112898Enrolling by invitation
Platelet-rich plasma for face and neck skin grafts
This study tests whether applying platelet-rich plasma (a concentration of healing cells from your own blood) to a face or neck skin graft helps the graft heal better and improves recovery. If you need a skin graft for an injury, burn, or after surgery, this might be an option for you.
Lahore, Punjab ProvinceAges 18–65 - NCT07053436RecruitingPhase 2
New treatment for high-risk myeloma before transplant
This study tests a new treatment combination for people with high-risk multiple myeloma who are newly diagnosed and healthy enough for a stem cell transplant. The goal is to see if the treatment can improve outcomes compared to standard therapy.
Atlanta, GeorgiaAges 18 years+ - NCT06575712Recruiting
Coping skills training to manage symptoms and daily steps
This study tests a coping skills training program to help people who have had a stem cell transplant or CAR-T cell therapy for blood cancer manage fatigue, pain, and stress. It may help you feel better and be more active in daily life.
Durham, North CarolinaAges 18–99 - NCT06749431Enrolling by invitation
Meniscus transplant study: long-term outcomes
This study looks at how well meniscus transplants work over time — including how long the graft lasts and how it protects knee cartilage. It may be a good fit if you are getting your first or a repeat meniscus transplant, sometimes along with other knee repairs.
Plano, TexasAges 10–65 - NCT07015723Enrolling by invitation
Liver fat study in living donors
This study looks at stored medical data from living liver donors to better understand fat in the liver (steatosis). It may help improve future transplant care.
Rotterdam, South HollandAges 18–60 - NCT07006532Recruiting
Tocilizumab for chronic active antibody-mediated rejection
This trial tests whether the drug tocilizumab can help treat chronic active antibody-mediated rejection after a kidney transplant. It is for people whose kidney function is still fairly good and who have certain findings on biopsy.
TehranAges 18 years+ - NCT06034535RecruitingPhase 2
A stem cell transplant trial using special donor cells
This trial tests a new way to give donor cells after a stem cell transplant to help the body accept them. It may help patients who need a transplant but don't have a perfectly matched donor.
Hong KongAges Up to 18 years - NCT05943964Recruiting
Online exercise rehab after stem cell transplant
This trial tests a virtual (online) exercise program to help people recover strength and function after an allogeneic stem cell transplant. It may help you keep moving safely from home, if your doctor clears you for exercise and you can do the sessions with the needed support.
Atlanta, GeorgiaAges 8–23 - NCT05654922RecruitingPhase 3
Prevent lung transplant airways scarring with ARINA-1
This Phase 3 trial tests ARINA-1 to slow or prevent worsening lung transplant scarring in the breathing tubes (bronchiolitis obliterans). It may help people who are showing early decline in lung function but are not yet at advanced disease.
Phoenix, ArizonaAges 18–75 - NCT07243717Recruiting
App-based support for potential kidney donors
This study tests a mobile app that provides information and support to people considering living kidney donation. It may help you make a more informed decision about donation.
TaoyuanAges 20–70 - NCT05843877RecruitingPhase 3
Surgery choice and insulin islet transplant to prevent leaks
This Phase 3 trial studies a pancreatic surgery approach (pylorus-preserving Whipple or similar) and, in some cases, moving your insulin-making cells into your body to help prevent a dangerous post-surgery leak from the pancreas. It may help people who are considered high risk for this complication based on pancreas texture and duct size.
DresdenAges 18 years+ - NCT06931808Enrolling by invitationPhase 4
Fecal transplant with chemo, radiation, and immunotherapy for advanced colon cancer
This study tests a combination of fecal microbiota transplant, chemotherapy, radiation, and immunotherapy (sintilimab) for people with locally advanced rectal cancer. The goal is to see if this approach improves treatment outcomes.
Ningbo, ZhejiangAges 18–75 - NCT07651748Enrolling by invitationPhase 1/Phase 2
Testing Secretin to Improve Donated Liver Quality
This trial tests whether adding a hormone called secretin to a machine that preserves donated livers outside the body can improve liver quality and transplant outcomes. You may qualify if you're an adult receiving a standard deceased-donor liver transplant that needs special preservation techniques.
Rotterdam, South HollandAges 18 years+ - NCT06912347Enrolling by invitation
Herbal therapy to prevent infection after stem cell transplant
This trial tests whether a special herbal treatment applied to the skin can help prevent infections around the bottom that are caused by diarrhea after a stem cell transplant. It may be an option for people who are getting a transplant for the first time.
Shanghai, Shanghai MunicipalityAges 14–70 - NCT05665140RecruitingPhase 2/Phase 3
Newly diagnosed myeloma study using blood-marker risk groups
This Phase 2/3 trial tests whether matching treatment choices to a patient’s myeloma risk pattern (using blood and scan results) improves outcomes. It is for people with newly diagnosed, untreated, symptomatic multiple myeloma who may also receive transplant-related treatment.
BerlinAges 18–70 - NCT06823622Recruiting
Digital transition care for teens with asthma or transplants
This trial tests a digital program to help teenagers with asthma, allergies, or organ transplants move from pediatric to adult healthcare. It aims to see if online support works as well as in-person visits.
Gothenburg, Vastra GotalandsregionenAges 15–20 - NCT06622187Enrolling by invitationPhase 4
Desmopressin to prevent bleeding during kidney biopsy
This trial tests if desmopressin can lower bleeding risk during a kidney transplant biopsy. It may help patients with reduced kidney function who need a biopsy.
Porto Alegre, Rio Grande do SulAges 18 years+
Hear when a new Transplantation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for transplantation?
- Yes. Clin2 currently lists 1,497 recruiting transplantation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a transplantation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a transplantation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.